Drugs / CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06646666 | Dec 2024 → Jun 2027 expected | B-cell non-Hodgkin lymphoma | Ruijin Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06646666 ↗ |
| Modality | Cell therapy | “CAR-T cell therapy” NCT06646666 ↗ |